Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Malaysian Journal of Medical Sciences : MJMS|September 24, 2014
Histopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosisNadine Alvarez, Juan Francisco Infante, Reinier Borrero, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessusDereje Abate Negatu, Andreas Beuchel, Abdeldjalil Madani, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential ResistanceJohn T Williams, Elizabeth R Haiderer, Garry B Coulson, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Omicron Subvariants Infection Kinetics and Nirmatrelvir Efficacy in Transgenic K18-hACE2 MiceVijeta Sharma, Enriko Dolgov, Taylor Tillery, et al.
Vaccine|July 9, 2011
Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in miceLissete Rodriguez, Yanelys Tirado, Fatima Reyes, et al.
The Journal of Experimental Medicine|July 19, 2018
Impact of immunopathology on the antituberculous activity of pyrazinamideLandry Blanc, Jansy Passiflora Sarathy, Nadine Alvarez Cabrera, et al.
BMC Immunology|March 6, 2013
Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infectionNadine Alvarez, Oscar Otero, Frank Camacho, et al.
International Journal of Molecular Sciences|October 16, 2025
Omicron Subvariants Infection Kinetics and Nirmatrelvir Efficacy in Transgenic K18-hACE2 MiceVijeta Sharma, Enriko Dolgov, Taylor Tillery, et al.
Human Vaccines & Immunotherapeutics|February 12, 2015
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosisYanely Tirado, Alina Puig, Nadine Alvarez, et al.
Pageof 3